User menu

Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group.

Bibliographic reference Blay, J. ; Hermans, Cédric ; Le Cesne, A. ; Whelan, Jeremy S. ; Van Oosterom, A. ; et. al. Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group..42nd Annual Meeting of the American-Society-of-Clinical-Oncology (Atlanta (Ga), Jun 02-06, 2006). In: Journal of Clinical Oncology, Vol. 24, no. 18, p. 524S-524S (2006)
Permanent URL http://hdl.handle.net/2078.1/59897